Recipes you want to make. Cooking advice that works. Restaurant recommendations you trust.
Recipes you want to make. Cooking advice that works. Restaurant recommendations you trust.
Surrozen Inc.’s back-end-loaded deal with Boehringer Ingelheim GmbH for the preclinical frizzled class receptor 4 agonist SZN-413 takes aim at vascular function in retinal diseases. The arrangement ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results